NCT04417452

Brief Summary

The primary objectives of the proposed project are to assess the long-term effects of prenatal exposure to gestational diabetes or diabetes on the maturation and health of the offspring. In addition, the long-term changes on the health of the affected mothers will be investigated, taking into account the metabolic adjustment during index pregnancy. The expected results will help to establish possible prevention strategies to fight the epidemic of non-communicable diseases for the offspring and the mothers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 14, 2023

Status Verified

April 1, 2023

Enrollment Period

3.2 years

First QC Date

April 15, 2020

Last Update Submit

April 12, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Metabolic health

    effects on metabolic health such as glucose tolerance disorders and diabetes mellitus, obesity and metabolic syndrome (mothers and children)

    1 day examination at the study centre

  • Neurocognitive development

    effects on neurocognitive development, mental health and adrenal and autonomic stress reactivity (mothers and children)

    1 day examination at the study centre

  • Cardiovascular and vascular health

    effects on cardiovascular and vascular health of blood pressure regulation and endothelial function (mothers and children)

    1 day examination at the study centre

  • Maturation of the gonadal regulation

    maturation of gonadal regulation, pubertal development and reproductive health (children)

    1 day examination at the study centre

Study Arms (2)

Mothers / children after diabetes in pregnancy

The study collective is composed of mother-child pairs after gestational diabetes, which were supervised in the Competence Center for Diabetes and Pregnancy at the University Hospital of Jena. The patients can decide to fill in an online questionnaire. For all other parts of the study, only patients who have been informed individually or on behalf of their legal guardian about the nature of the study after a detailed and understandable explanatory discussion with an investigator and who have given written consent will be included in the study.

Other: Basic data collection (online survey or written form)Other: Physical examinationBehavioral: Psychometric examinationDiagnostic Test: Recording of the adrenergic stress reaction (saliva test)

Controls

The control collective is composed of mother-child pairs who were cared for at the same time as the study collective at the University Hospital Jena. This collective is status post singleton pregnancy and term birth. The patients can decide to fill in an online questionnaire. For all other parts of the study, only patients who have been informed individually or on behalf of their legal guardian about the nature of the study after a detailed and understandable explanatory discussion with an investigator and who have given written consent will be included in the study.

Other: Basic data collection (online survey or written form)Other: Physical examinationBehavioral: Psychometric examinationDiagnostic Test: Recording of the adrenergic stress reaction (saliva test)

Interventions

Basic data collection is carried out by means of a questionnaire that participants can fill in outside the study centre. It contains questions about the current life situation, sleep and activity behaviour.

ControlsMothers / children after diabetes in pregnancy

The physical examination takes place at the study centre and includes the measurement of height, current weight and body fat, as well as the recording of heart and circulation parameters (e.g. blood pressure measurement or determination of vascular health by means of ultrasound). General metabolic and hormonal parameters are analysed by means of a blood sample. In addition, a sugar test for diabetes diagnosis will be carried out.

ControlsMothers / children after diabetes in pregnancy

Psychometric examination is carried out at the study centre with the help of a RIAS (Reynolds Intellectual Assessment Scales and Screening) test.

ControlsMothers / children after diabetes in pregnancy

The adrenergic stress reaction is recorded by a saliva test.

ControlsMothers / children after diabetes in pregnancy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study collective is composed of mother-child pairs after gestational diabetes, which were supervised in the Competence Center for Diabetes and Pregnancy at the University Hospital of Jena. The patients can decide to fill in an online questionnaire. For all other parts of the study, only patients who have been informed independently or on behalf of their legal guardian about the nature of the study after a detailed and understandable explanatory discussion with an investigator and who have given written consent will be included in the study.

You may qualify if:

  • For the pilot project: Initial participation in the preliminary study
  • Written Informed Consent
  • Singleton pregnancies
  • Delivery at the University Hospital Jena

You may not qualify if:

  • Severe physical and mental illness
  • Patients who refuse to participate in the study or drop out
  • Premature birth, i.e. birth of the child \<37/0 weeks of gestation
  • Serious pregnancy complications
  • Prenatally known serious malformations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Jena

Jena, Thuringia, 07747, Germany

Location

MeSH Terms

Conditions

Diabetes, Gestational

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Friederike Weschenfelder, Dr. med.

    Klinik für Geburtsmedizin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2020

First Posted

June 4, 2020

Study Start

September 1, 2019

Primary Completion

October 25, 2022

Study Completion

December 31, 2023

Last Updated

April 14, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations